{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:29:36Z","timestamp":1791318576130,"version":"4.3.1"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100006315","name":"Dutch Arthritis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006315","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Netherlands Organization for Scientific Research","award":["14-2-402"],"award-info":[{"award-number":["14-2-402"]}]},{"name":"IMI JU","award":["115142-2"],"award-info":[{"award-number":["115142-2"]}]},{"name":"The Netherlands Proteomics Center","award":["91712334"],"award-info":[{"award-number":["91712334"]}]},{"name":"Center for Medical Systems Biology"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.jaut.2017.02.008","type":"journal-article","created":{"date-parts":[[2017,3,10]],"date-time":"2017-03-10T22:17:36Z","timestamp":1489184256000},"page":"77-84","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["Identification of carbamylated alpha 1 anti-trypsin (A1AT) as an antigenic target of anti-CarP antibodies in patients with rheumatoid arthritis"],"prefix":"10.1016","volume":"80","author":[{"given":"Marije K.","family":"Verheul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4879-7904","authenticated-orcid":false,"given":"Alvin","family":"Yee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Seaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George M.","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"van Veelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan W.","family":"Drijfhout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rene E.M.","family":"Toes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Mahler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leendert A.","family":"Trouw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jaut.2017.02.008_bib1","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1136\/annrheumdis-2015-208870","article-title":"The association between anti-carbamylated protein (anti-CarP) antibodies and radiographic progression in early rheumatoid arthritis: a study exploring replication and the added value to ACPA and rheumatoid factor","volume":"76","author":"Ajeganova","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2017.02.008_bib2","doi-asserted-by":"crossref","first-page":"e000172","DOI":"10.1136\/rmdopen-2015-000172","article-title":"Predictive factors of radiological progression after 2 years of remission-steered treatment in early arthritis patients: a post hoc analysis of the IMPROVED study","volume":"2","author":"Akdemir","year":"2016","journal-title":"RMD Open"},{"key":"10.1016\/j.jaut.2017.02.008_bib3","first-page":"824","article-title":"Anti-carbamylated protein antibodies in unaffected first-degree relatives of rheumatoid arthritis patients: lack of correlation with anti-cyclic citrullinated protein antibodies and rheumatoid factor","volume":"33","author":"Alessandri","year":"2015","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jaut.2017.02.008_bib4","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"Rheumatoid arthritis classification criteria: an American college of rheumatology\/European league against rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2017.02.008_bib5","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1136\/ard.2010.138461","article-title":"Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League against Rheumatism collaborative initiative","volume":"69","author":"Aletaha","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2017.02.008_bib6","doi-asserted-by":"crossref","first-page":"175ra29","DOI":"10.1126\/scitranslmed.3005218","article-title":"Carbamylation of serum albumin as a risk factor for mortality in patients with kidney failure","volume":"5","author":"Berg","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jaut.2017.02.008_bib7","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1136\/annrheumdis-2015-207751","article-title":"Antibodies against carbamylated proteins are present in primary Sjogren's syndrome and are associated with disease severity","volume":"75","author":"Bergum","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2017.02.008_bib8","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13075-015-0536-2","article-title":"Anti-carbamylated protein antibodies in the pre-symptomatic phase of rheumatoid arthritis, their relationship with multiple anti-citrulline peptide antibodies and association with radiological damage","volume":"17","author":"Brink","year":"2015","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2017.02.008_bib9","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.autrev.2015.08.003","article-title":"Auto-reactions, autoimmunity and psoriatic arthritis","volume":"14","author":"Chimenti","year":"2015","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2017.02.008_bib10","first-page":"1216","article-title":"Rheumatoid arthritis and alpha-1-antitrypsin","volume":"1","author":"Cox","year":"1976","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2017.02.008_bib11","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1399-0004.1980.tb00125.x","article-title":"Association of severe rheumatoid arthritis with heterozygosity for alpha 1-antitrypsin deficiency","volume":"17","author":"Cox","year":"1980","journal-title":"Clin. Genet."},{"key":"10.1016\/j.jaut.2017.02.008_bib12","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/ar4565","article-title":"Moving towards personalized medicine in rheumatoid arthritis","volume":"16","author":"de Jong","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2017.02.008_bib13","first-page":"73","article-title":"Homocitrulline: a new marker for differentiating acute from chronic renal failure","volume":"54","author":"Desmons","year":"2015","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.jaut.2017.02.008_bib14","doi-asserted-by":"crossref","first-page":"572","DOI":"10.3899\/jrheum.140767","article-title":"Anti-carbamylated protein antibodies are present prior to rheumatoid arthritis and are associated with its future diagnosis","volume":"42","author":"Gan","year":"2015","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.jaut.2017.02.008_bib15","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/jgm.1409","article-title":"Combination of alpha-1 antitrypsin and doxycycline suppresses collagen-induced arthritis","volume":"12","author":"Grimstein","year":"2010","journal-title":"J.\u00a0Gene Med."},{"key":"10.1016\/j.jaut.2017.02.008_bib16","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1479-5876-9-21","article-title":"Alpha-1 antitrypsin protein and gene therapies decrease autoimmunity and delay arthritis development in mouse model","volume":"9","author":"Grimstein","year":"2011","journal-title":"J.\u00a0Transl. Med."},{"key":"10.1016\/j.jaut.2017.02.008_bib17","article-title":"Anticarbamylated protein antibodies are associated with long-term disability and increased disease activity in patients with early inflammatory arthritis: results from the norfolk arthritis register","author":"Humphreys","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2017.02.008_bib18","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1136\/annrheumdis-2013-205109","article-title":"Anti-CarP antibodies in two large cohorts of patients with rheumatoid arthritis and their relationship to genetic risk factors, cigarette smoking and other autoantibodies","volume":"73","author":"Jiang","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2017.02.008_bib19","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1586\/14737159.2015.1002470","article-title":"Companion diagnostics: the key to personalized medicine, foreword","volume":"15","author":"Jorgensen","year":"2015","journal-title":"Expert. Rev. Mol. Diagn."},{"key":"10.1016\/j.jaut.2017.02.008_bib20","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1136\/annrheumdis-2014-206785","article-title":"Identification of novel antiacetylated vimentin antibodies in patients with early inflammatory arthritis","volume":"75","author":"Juarez","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2017.02.008_bib21","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/art.1780220202","article-title":"Alpha-1-antitrypsin phenotypes in rheumatoid arthritis and systemic lupus erythematosus","volume":"22","author":"Karsh","year":"1979","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2017.02.008_bib22","doi-asserted-by":"crossref","first-page":"e0159000","DOI":"10.1371\/journal.pone.0159000","article-title":"Meta-analysis: diagnostic Accuracy of anti-carbamylated protein antibody for rheumatoid arthritis","volume":"11","author":"Li","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2017.02.008_bib23","doi-asserted-by":"crossref","first-page":"e0161141","DOI":"10.1371\/journal.pone.0161141","article-title":"Anti-carbamylated protein antibodies as a reproducible independent type of rheumatoid arthritis autoantibodies","volume":"11","author":"Montes","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2017.02.008_bib24","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s13075-016-1001-6","article-title":"Antibodies to carbamylated alpha-enolase epitopes in rheumatoid arthritis also bind citrullinated epitopes and are largely indistinct from anti-citrullinated protein antibodies","volume":"18","author":"Reed","year":"2016","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2017.02.008_bib25","first-page":"850","article-title":"Rheumatoid arthritis patients have anti-homocitrullinated fibrinogen antibodies","volume":"63","author":"Scinocca","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2017.02.008_bib26","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3899\/jrheum.130742","article-title":"Antihomocitrullinated fibrinogen antibodies are specific to rheumatoid arthritis and frequently bind citrullinated proteins\/peptides","volume":"41","author":"Scinocca","year":"2014","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.jaut.2017.02.008_bib27","doi-asserted-by":"crossref","first-page":"370S","DOI":"10.1042\/bst025370s","article-title":"Comparison of IgA-alpha 1-antitrypsin levels in rheumatoid and reactive arthritis","volume":"25","author":"Scott","year":"1997","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.jaut.2017.02.008_bib28","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1093\/rheumatology\/37.4.398","article-title":"Comparison of IgA-alpha1-antitrypsin levels in rheumatoid arthritis and seronegative oligoarthritis: complex formation is not associated with inflammation per se","volume":"37","author":"Scott","year":"1998","journal-title":"Br. J. Rheumatol."},{"key":"10.1016\/j.jaut.2017.02.008_bib29","doi-asserted-by":"crossref","first-page":"17372","DOI":"10.1073\/pnas.1114465108","article-title":"Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage","volume":"108","author":"Shi","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jaut.2017.02.008_bib30","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1136\/annrheumdis-2013-204154","article-title":"Anti-carbamylated protein (anti-CarP) antibodies precede the onset of rheumatoid arthritis","volume":"73","author":"Shi","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2017.02.008_bib31","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/art.37830","article-title":"Anti Carbamylated Protein Antibodies (anti-CarP) are present in arthralgia patients and predict the development of rheumatoid arthritis","volume":"65","author":"Shi","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2017.02.008_bib32","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1186\/s13075-015-0860-6","article-title":"The specificity of anti-carbamylated protein antibodies for rheumatoid arthritis in a setting of early arthritis","volume":"17","author":"Shi","year":"2015","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2017.02.008_bib33","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.autrev.2013.10.008","article-title":"Carbamylation and antibodies against carbamylated proteins in autoimmunity and other pathologies","volume":"13","author":"Shi","year":"2014","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2017.02.008_bib34","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1136\/annrheumdis-2012-201559","article-title":"Recognition of citrullinated and carbamylated proteins by human antibodies: specificity, cross-reactivity and the 'AMC-Senshu' method","volume":"72","author":"Shi","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2017.02.008_bib35","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.autrev.2012.05.007","article-title":"Closing the serological gap: promising novel biomarkers for the early diagnosis of rheumatoid arthritis","volume":"12","author":"Trouw","year":"2012","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2017.02.008_bib36","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/nrrheum.2011.76","article-title":"Anti-CCP antibodies: the past, the present and the future","volume":"7","author":"van Venrooij","year":"2011","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jaut.2017.02.008_bib37","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1093\/rheumatology\/kev250","article-title":"Anti-carbamylated protein antibodies in rheumatoid arthritis patients of Asian descent","volume":"54","author":"Verheul","year":"2015","journal-title":"Rheumatol. Oxf."},{"key":"10.1016\/j.jaut.2017.02.008_bib38","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.autrev.2010.08.009","article-title":"All you wanted to know about anti-CCP but were afraid to ask","volume":"10","author":"Wiik","year":"2010","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2017.02.008_bib39","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s12026-014-8560-x","article-title":"Anti-CarP antibodies as promising marker to measure joint damage and disease activity in patients with rheumatoid arthritis","volume":"61","author":"Yee","year":"2015","journal-title":"Immunol. Res."}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841116302633?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841116302633?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:15:26Z","timestamp":1760256926000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841116302633"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":39,"alternative-id":["S0896841116302633"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2017.02.008","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of carbamylated alpha 1 anti-trypsin (A1AT) as an antigenic target of anti-CarP antibodies in patients with rheumatoid arthritis","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2017.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}